Cristal Therapeutics
2 known investors
Cristal Therapeutics develops a proprietary copper-free click chemistry platform, CliCr®, used to create bioconjugate products with higher stability and faster reaction rates. The company licenses its CliCr® technology to partners for diagnostic and therapeutic applications.
BiotechDeep Tech
Investors · 2
Frequently asked questions
- What does Cristal Therapeutics do?
- Cristal Therapeutics develops a proprietary copper-free click chemistry platform, CliCr®, used to create bioconjugate products with higher stability and faster reaction rates. The company licenses its CliCr® technology to partners for diagnostic and therapeutic applications.
- Who are Cristal Therapeutics's investors?
- Cristal Therapeutics's investors include BOM, Droia Ventures.